Clinical Trials Browser

Phase 2 × Lymphoma × ixazomib × Clear all

NCT02924272 2025-03-12

Ixazomib Rollover Study

Phase 2 Completed

32 enrolled 13 charts

LymphoidPlasma cell

Amyloidosis, Lymphoma, Multiple Myeloma

NCT02169791 2021-09-02

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Phase 2 Completed

29 enrolled 14 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms